1981
DOI: 10.1016/s0140-6736(81)90071-4
|View full text |Cite
|
Sign up to set email alerts
|

HYPERCALCAEMIA IN HOSPITAL PATIENTS Clinical and Diagnostic Aspects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
25
0
1

Year Published

1983
1983
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 111 publications
(27 citation statements)
references
References 22 publications
1
25
0
1
Order By: Relevance
“…Hypercalcemia is a secondary metabolic phenomenon occurring in approximately 58% of hospitalized patients with cancer [1].Thiscomplicationisdefinedasmalignancy-associatedhypercalcemia(MAH)andcanbecategorizedintotwo cardinal groups: the humoral hypercalcemia of malignancy (HHM),duetosystemicboneresorptionbyseveralhumoral factorsproducedandsecretedbythemalignanttumoritself, andthelocalosteolytichypercalcemiaofmalignancy(LOH), duetolocalosteolysisinducedbybonemetastasis [2].Many studiesoverthelastdecadeshavereachedtheconclusionthat the major agent inducing HHM is the so-called parathyroid hormone-related peptide (PTH-rP) [3]. PTH-rP was discoveredinthemid1980s,thusestablishinganimportantadvancementintheunderstandingofmalignancy-associatedhypercalcemias [4].PTH-rPisexpressedandsecretedbyavarietyof normal human tissues, including amnion, chorion, placenta, myometrium and decidua during pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…Hypercalcemia is a secondary metabolic phenomenon occurring in approximately 58% of hospitalized patients with cancer [1].Thiscomplicationisdefinedasmalignancy-associatedhypercalcemia(MAH)andcanbecategorizedintotwo cardinal groups: the humoral hypercalcemia of malignancy (HHM),duetosystemicboneresorptionbyseveralhumoral factorsproducedandsecretedbythemalignanttumoritself, andthelocalosteolytichypercalcemiaofmalignancy(LOH), duetolocalosteolysisinducedbybonemetastasis [2].Many studiesoverthelastdecadeshavereachedtheconclusionthat the major agent inducing HHM is the so-called parathyroid hormone-related peptide (PTH-rP) [3]. PTH-rP was discoveredinthemid1980s,thusestablishinganimportantadvancementintheunderstandingofmalignancy-associatedhypercalcemias [4].PTH-rPisexpressedandsecretedbyavarietyof normal human tissues, including amnion, chorion, placenta, myometrium and decidua during pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…The most common causes of hypercalcemia in hospital patients without a known diagnosis are either hyperparathyroidism or malignancy [6]. Fisken et al evaluated 166 hospital inpatients with hypercalcemia at admission.…”
Section: Differential Diagnosismentioning
confidence: 99%
“…Tumors most frequently associated with hypercalcemia are carcinomas of the lung or breast, tumors of the genitourinary tract, and those of unknown origin [6,12,20]. Because there were no abnormalities on the chest X-ray, X-ray of the vertebral column, computed tomographic scans of the thorax and abdomen, or the mammogram, these conditions appeared less likely.…”
Section: Differential Diagnosismentioning
confidence: 99%
See 1 more Smart Citation
“…In most clinical situations hypercalcemia is caused by primary hyperparathyroidism (PHP) or malignancy [1,2]. Because the excretion of urinary cAMP (cyclic 3',5' adenosine monophosphate) has been proved to be a good measurement of the biological activity of parathyroid hormone (PTH) in PHP some investigators started measuring urinary cAMP excretion in hypercalcemic patients with a malignant tumor in an attempt to differentiate between the hypercalcemia of PHP and of malignancy [3][4][5].…”
Section: Introductionmentioning
confidence: 99%